Compare Alcon AG (ALC) vs Baxter International Inc (BAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alcon AG vs Baxter International Inc — how do they compare? Alcon AG trades at $72.96 (market cap $36.44B), while Baxter International Inc trades at $27.61 (market cap $14.27B). The key difference: Alcon AG is far larger — about 2.6× Baxter International Inc's market cap, and Alcon AG pays the higher dividend (0.48%). Which is the better fit depends on your goals.
| ALC | BAX | |
|---|---|---|
Market Cap | $36.44B | $14.27B |
Sector | Health | Health |
52-Week High | $90.12 | $28.35 |
52-Week Low | $62.02 | $15.80 |
Enterprise Value | $40.28B | $21.79B |
Dividend Yield | 0.48% | 0.14% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Baxter International Inc
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →
